Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion for Methamphetamine Dependence
NCT00135785Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Oct 2005
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in methamphetamine use disorder (MUD) comparing Bupropion with Placebo (2 arms). Primary endpoints: Addiction severity at Week 16 and Drug use at Week 16. Started Oct 2005; status: completed.
02
Drugs
bupropion
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT00135785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00135785.